The package of bills are designed to link the prices Americans pay for prescription drugs to lower costs in other countries.
The death rate from cancer in the U.S. fell 27 percent between 1991 and 2016 due to earlier detection and a decline in smoking, according to a new study by the American Cancer Society. But obesity-related cancer deaths are increasing,…
By Mike Stobbe, Associated Press
NEW YORK — The U.S. cancer death rate has hit a milestone: It’s been falling for at least 25 years, according to a new report. Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also…
By Danica Coto, Associated Press
"Hardly anyone talks about this problem in Puerto Rico. It's like it doesn't exist," says Rafael Torruella, program director for a needle exchange program in Puerto Rico.
Looking for diseases in newborns’ DNA that could arise during adulthood is more ethically fraught than focusing on childhood conditions.
By Ricardo Alonso-Zaldivar, Associated Press
Democratic attorneys general on Thursday appealed a federal court ruling that the Affordable Care Act is unconstitutional, as new enrollment numbers underscored the staying power of the Obama-era law.
The nation’s opioid crisis was declared a public health emergency in 2017 and received new funding this past October. But rampant addiction led to some 40,000 overdose deaths in the U.S. last year, and 2019 could see the culmination of…
These ideas can improve both your physical and emotional wellbeing in 2019.
By David A. Lieb, Associated Press
Big-dollar decisions about health care and education will lead the agenda in many state capitols as lawmakers convene for their 2019 sessions with a closer balance between Republicans and Democrats.
By Michael R. Blood, Associated Press
At year's end, California's effort to transform its longstanding illegal and medicinal marijuana markets into a unified, multibillion-dollar industry remains a work in progress.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.